A detailed history of Roanoke Asset Management Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Roanoke Asset Management Corp holds 10,000 shares of CORT stock, worth $343,800. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$343,800
Previous $252,000 28.97%
% of portfolio
0.11%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$19.2 - $24.47 $96,000 - $122,350
-5,000 Reduced 33.33%
10,000 $217,000
Q2 2022

Aug 10, 2022

SELL
$17.33 - $25.3 $86,649 - $126,500
-5,000 Reduced 25.0%
15,000 $357,000
Q1 2022

May 11, 2022

BUY
$16.53 - $25.21 $330,600 - $504,200
20,000 New
20,000 $450,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.68B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Roanoke Asset Management Corp Portfolio

Follow Roanoke Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.